Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bonomi

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Cancer|January 28, 1998
A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587)A Y Chang, K Kim, H Boucher, et al.
Seminars in Oncology|April 1, 1988
Megestrol acetate as primary hormonal therapy for advanced breast cancerP A Johnson, H Muss, P Bonomi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Activity of docetaxel in platinum-treated non-small-cell lung cancer: results of a phase II multicenter trialD R Gandara, E Vokes, M Green, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1988
Concomitant therapy with infusion of cisplatin and 5-fluorouracil plus radiation in stage III non-small cell lung cancerS G Taylor, A K Murthy, P Bonomi, et al.
Investigational New Drugs|January 1, 1995
Phase II trial of gallium nitrate, amonafide and teniposide in metastatic non-small cell lung cancer. An Eastern Cooperative Oncology Group study (E2588)A Y Chang, Z N Tu, J L Smith, et al.
Cancer Treatment Reports|February 1, 1986
Treatment of soft tissue sarcoma with fibroblast interferon (beta-interferon): an American Cancer Society/Illinois Cancer Council StudyJ Harris, T Das Gupta, N Vogelzang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2000
Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancerC P Belani, A Einzig, P Bonomi, et al.
Anticancer Research|September 1, 1996
An in vivo inhibitor of 5-lipoxygenase, MK886, at micromolar concentration induces apoptosis in U937 and CML cellsK M Anderson, T Seed, A Jajeh, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 1, 1997
A 5-lipoxygenase inhibitor at micromolar concentration raises intracellular calcium in U937 cells prior to their physiologic cell deathT Buyn, P Dudeja, J E Harris, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 11, 2002
Increased cytosol Ca(2+) and type 1 programmed cell death in Bcl-2-positive U937 but not in Bcl-2-negative PC-3 and Panc-1 cells induced by the 5-lipoxygenase inhibitor MK 886K M Anderson, W A Alrefai, P K Dudeja, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Cancer|January 28, 1998
A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587)A Y Chang, K Kim, H Boucher, et al.
Seminars in Oncology|April 1, 1988
Megestrol acetate as primary hormonal therapy for advanced breast cancerP A Johnson, H Muss, P Bonomi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Activity of docetaxel in platinum-treated non-small-cell lung cancer: results of a phase II multicenter trialD R Gandara, E Vokes, M Green, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1988
Concomitant therapy with infusion of cisplatin and 5-fluorouracil plus radiation in stage III non-small cell lung cancerS G Taylor, A K Murthy, P Bonomi, et al.
Investigational New Drugs|January 1, 1995
Phase II trial of gallium nitrate, amonafide and teniposide in metastatic non-small cell lung cancer. An Eastern Cooperative Oncology Group study (E2588)A Y Chang, Z N Tu, J L Smith, et al.
Cancer Treatment Reports|February 1, 1986
Treatment of soft tissue sarcoma with fibroblast interferon (beta-interferon): an American Cancer Society/Illinois Cancer Council StudyJ Harris, T Das Gupta, N Vogelzang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2000
Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancerC P Belani, A Einzig, P Bonomi, et al.
Anticancer Research|September 1, 1996
An in vivo inhibitor of 5-lipoxygenase, MK886, at micromolar concentration induces apoptosis in U937 and CML cellsK M Anderson, T Seed, A Jajeh, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 1, 1997
A 5-lipoxygenase inhibitor at micromolar concentration raises intracellular calcium in U937 cells prior to their physiologic cell deathT Buyn, P Dudeja, J E Harris, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 11, 2002
Increased cytosol Ca(2+) and type 1 programmed cell death in Bcl-2-positive U937 but not in Bcl-2-negative PC-3 and Panc-1 cells induced by the 5-lipoxygenase inhibitor MK 886K M Anderson, W A Alrefai, P K Dudeja, et al.
Pageof 10